ATS: Upfront Combination Versus Monotherapy in Pulmonary Arterial Hypertension (PAH): Can Advanced Risk Stratification Tell Us the Real Benefit?
J.V. Scott, L.C. Lohmueller , C.G. Garnett , M.K. Kanwar , R.L. Benza. A105 GLORY DAYS: THE LATEST CLINICAL RESEARCH IN PAH / Poster Discussion Session / American Thoracic Society 2019;199:A7346 Rationale: The Registry to Evaluate Early and Long-Term PAH Disease Management recently updated their linear multivariable risk-stratification tool (REVEAL 2.0). Our ongoing study aims […]